Acromegaly Clinical Trials

A listing of Acromegaly medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 23 clinical trials
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly

The purpose of this trial is to assess the efficacy and safety of CAM2029 in patients with acromegaly. Patients will be randomized to either CAM2029 or placebo administered subcutaneously once

lanreotide
somatomedin c
insulin-like growth factor
hepatic disease
octreotide
  • 79 views
  • 07 Oct, 2022
  • 65 locations
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-1)

) in subjects with acromegaly previously treated with somatostatin receptor ligand (SRL) based treatment regimens.

somatostatin
insulin-like growth factor
igf1
  • 14 views
  • 07 Oct, 2022
  • 54 locations
A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly

The purpose of this trial is to assess the long-term safety of CAM2029 in patients with acromegaly. Patients will be administered CAM2029 subcutaneously once monthly during 12 months. Patients

lanreotide
somatomedin c
insulin-like growth factor
pituitary
hepatic disease
  • 325 views
  • 07 Oct, 2022
  • 66 locations
  • 3 views
  • 24 Oct, 2022
  • 23 locations
Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor (GA-9)

Modulation of the GIP System in Patients With Acromegaly Due to a Pituitary adenoma

  • 11 views
  • 15 Feb, 2022
  • 1 location
Very Large Sizes in Adolescents : Tibial and Femoral EPIphysiodesis (GREPI)

The very large sizes can be very disabling and at the origin of a difficult psychological experience. Some families are in demand for a growth-curbing treatment. Currently, only hormonal treatments are offered in France but they are at the origin of many side effects. Northern European countries applied a surgical …

  • 0 views
  • 04 Oct, 2022
  • 4 locations
Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

This study will be conducted at Children's Healthcare of Atlanta, in Atlanta, Georgia for a total duration of 24 months. The electrical neuromuscular stimulation device used in this study is the VitalStim 400, which has been used in multiple previous clinical studies for modulation of pain and has received FDA …

immune globulin
polyneuropathy
igiv
plasma exchange
  • 0 views
  • 07 Oct, 2022
  • 1 location
  • 0 views
  • 21 Oct, 2022
  • 2 locations
Growth Hormone as a Model for Reversible Activation of Adipose Tissue Fibrosis

adipose tissue lipolysis and stimulates collagen synthesis in lean tissues. Intriguingly, we have novel pilot data to suggest that GH excess (acromegaly) also induces reversible fibrosis in vivo and

  • 15 views
  • 10 Sep, 2021
  • 1 location
An Open-Label Phase 3 Study of the Safety and Efficacy of Pegvisomant in Children With Growth Hormone Excess

Background For children with gigantism, too much growth hormone (GH) in the body causes abnormal growth and many other problems. Current treatments often don t work; no medical treatment is approved by FDA. Researchers want to see if the drug pegvisomant can help. Objective To test the role of pegvisomant …

medical therapy
pituitary tumor
igf-i
hand x-ray
growth hormone
  • 5 views
  • 12 Oct, 2022
  • 1 location